Yang Yuan, Li Wen, Zhang Qinge, Zhang Ling, Cheung Teris, Ng Chee H, Xiang Yu-Tao
Unit of Psychiatry, Department of Public Health and Medicinal Administration, & Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.
Centre for Cognitive and Brain Sciences, University of Macau, Macao SAR, China.
Int J Biol Sci. 2021 Apr 10;17(6):1443-1445. doi: 10.7150/ijbs.57750. eCollection 2021.
The coronavirus disease-19 (COVID-19) has spread throughout the world, affecting many vulnerable populations including patients with severe mental illness (SMI). Recent studies have found that patients with SMI compared to the general population could have a greater risk of morbidity and mortality from COVID-19 due to cognitive impairment, poor awareness of risk, and difficulties in complying with infection control measures. Although some researchers have suggested that patients with SMI should be prioritized for COVID-19 vaccination to reduce the risk of infection, this issue remains controversial.
新型冠状病毒肺炎（COVID-19）已在全球蔓延，影响了许多弱势群体，包括重症精神疾病（SMI）患者。最近的研究发现，与普通人群相比，SMI患者因认知障碍、风险意识淡薄以及难以遵守感染控制措施，感染COVID-19后发病和死亡风险可能更高。尽管一些研究人员建议应优先为SMI患者接种COVID-19疫苗以降低感染风险，但这一问题仍存在争议。
